CD8A and neoplasm: Basically, strategies to reverse ICB tolerance are currently being explored (Table 1), which can be outlined as (1) releasing tumor antigens; (2) enhancing antigen presentation; (3) promoting T-cell infiltration; (4) reversing T-cell exhaustion; and (5) CD8+ T-cell stimulation.